Back to
BARCLAYS PLC
VKTX
Showing 8 of 31 quarters
Position history for
BARCLAYS PLC's holdings in VIKING THERAPEUTICS INC
Yes. Barclays holds 52,991 shares of VKTX (Viking Therapeutics), worth $2.1M, as of its Q2 2026 13F filing. It reduced the position by 17,288 shares (-24.6%) from Q1 2026. Barclays has held VKTX in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$2.1M
Current Shares
52,991
Total Value Change
-$4.5M
Total Shares Change
-50,140
Quarter-by-Quarter History